Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation

BMC Public Health

Scott A Halperin⁴  David W Scheifele⁶  Janet McElhaney⁹  Ethan Rubinstein⁸  Mark Loeb¹  Brenda Coleman⁷  Curtis Cooper²  Marc Dionne⁵  Brian J Ward³  Shelly McNeil⁴  Julie A Bettinger⁶  Amy Schneeberg⁶ 

[1] McMaster University, Hamilton, Ontario, Canada;The Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada;Vaccine Study Centre, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada;Canadian Center for Vaccinology, Dalhousie University, Capital Health and IWK Health Centre Halifax, Halifax, Nova Scotia, Canada;Research Center, Centre Hospitalier Universitaire, Quebec City, Quebec, Canada;Vaccine Evaluation Center, British Columbia Children’s Hospital and the University of British Columbia, Vancouver, British Columbia, Canada;University of Toronto and Mount Sinai Hospital, Toronto, Ontario, Canada;University of Manitoba, Department of Medicine, Winnipeg, Manitoba, Canada;University of British Columbia, VITALiTY Research Center, Vancouver, British Columbia, Canada

关键词: Older adults;    Polysaccharide pneumococcal vaccine;    Invasive pneumococcal disease;   

Others  :  1131436
DOI  :  10.1186/1471-2458-14-442

 received in 2013-06-25, accepted in 2014-05-02,  发布年份 2014

【 摘 要 】

Background

Fewer Canadian seniors are vaccinated against pneumococcal disease than receive the influenza vaccine annually. Improved understanding of factors influencing pneumococcal vaccination among older adults is needed to improve vaccine uptake.

Methods

A self-administered survey measuring knowledge, attitudes, beliefs and behaviours about pneumococcal vaccination was administered to a cohort of seniors participating in a clinical trial of seasonal influenza vaccines at eight centers across Canada. Eligible participants were ambulatory adults 65 years of age or older, in good health or with stable health conditions, previously given influenza vaccine. The primary outcome was self-reported receipt of pneumococcal vaccination. Multi-variable logistic regression was used to determine factors significantly associated with pneumococcal vaccine receipt.

Results

A total of 863 participants completed questionnaires (response rate 92%); 58% indicated they had received the pneumococcal vaccine. Being offered the vaccine by a health care provider had the strongest relationship with vaccine receipt (AOR 23.4 (95% CI 13.4-40.7)). Other variables that remained significantly associated with vaccine receipt in the multivariable model included having heard of the vaccine (AOR 10.1(95% CI 4.7-21.7)), and strongly agreeing that it is important for adults > 65 to be vaccinated against pneumococcus (AOR 3.3 (95% CI 1.2-9.2)). Participants who were < 70 years of age were less likely to be vaccinated.

Conclusions

These results indicate healthcare recommendation significantly influenced vaccine uptake in this population of older adults. Measures to encourage healthcare providers to offer the vaccine may help increase coverage.

【 授权许可】

   
2014 Schneeberg et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Public Health Agency of Canada: Vaccine Preventable Diseases: Invasive Pneumococcal Disease. 2011. http://www.phac-aspc.gc.ca/im/vpd-mev/index-eng.php webcite
• [2]Kohlhammer Y, Schnoor M, Schwartz M, Raspe H, Schäfer T: Determinants of influenza and pneumococcal vaccination in elderly people: a systematic review. Public Health 2007, 121:742-51.
• [3]Group ER: Canadian Adult National Immunization Coverage (Adult NICS) Survey. 2006.
• [4]Public Health Agency of Canada (PHAC): Canadian Immunization Guide - Public Health Agency of Canada. 2007.
• [5]Pfizer Canada Inc: Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine) Product Monograph. Kirkland; 2014.
• [6]National Advisory Committee on Immunization - Public Health Agency of Canada: Update on the use of conjugate pneumococcal vaccines in childhood. Canada Commun Dis Rep 2010.
• [7]Frenck RW, Yeh S: The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults. Expert Opin Biol Ther 2012, 12:63-77.
• [8]Ajzen I: The theory of planned behavior. Organ Behav Hum Decis Process 1991, 50:179-211.
• [9]Janz NK, Becker MH: The health belief model: a decade later. Heal Educ Behav 1984, 11:1-47.
• [10]Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A: A global clinical measure of fitness and frailty in elderly people. CMAJ 2005, 173:489-95.
• [11]Nichol KL, Mac Donald R, , Hauge M: Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med 1996, 11:673-7.
• [12]Evans MR, Watson P: Why do older people not get immunised against influenza? a community survey. Vaccine 2003, 21:2421-2427.
• [13]Nowalk MP, Zimmerman RK, Shen S, Jewell IK, Raymund M: Barriers to pneumococcal and influenza vaccination in older community-dwelling adults (2000–2001). J Am Geriatr Soc 2004, 52:25-30.
• [14]Ehresmann KR, Ramesh A, Como-Sabetti K, Peterson DC, Whitney CG, Moore KA: Factors associated with self-reported pneumococcal immunization among adults 65 years of age or older in the Minneapolis-St. Paul metropolitan area. Prev Med (Baltim) 2001, 32:409-15.
• [15]Lau D, Hu J, Majumdar SR, Storie DA, Rees SE, Johnson JA: Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: a systematic review and meta-analysis. Ann Fam Med 2012, 10:538-46.
• [16]Huss A, Scott P, Stuck AE, Trotter C, Egger M: Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009, 180:48-58.
• [17]Wagner C, Popp W, Posch M, Vlasich C, Rosenberger-Spitzy A: Impact of pneumococcal vaccination on morbidity and mortality of geriatic patients: a case-controlled study. Gerontology 2003, 49(4):246-250.
• [18]Sharpiro E, Berg A, Austrian R, Schroeder D, Parcells V, Margolis A, Adair R, JD C: The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991, 325(21):1453-60.
• [19]Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, Hospital-Guardiola I: Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study. Clin Infect Dis 2014, 58:909-17.
• [20]Wiemken TL, Carrico RM, Klein SL, Jonsson CB, Peyrani P, Kelley RR, Aliberti S, Blasi F, Fernandez-Gonzalez R, Lopardo G, Ramirez JA: The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the community-acquired pneumonia organi. Vaccine 2014, 32:2198-203.
• [21]Mieczkowski TA, Wilson SA: Adult pneumococcal vaccination: a review of physician and patient barriers. Vaccine 2002, 20:1383-1392.
• [22]Szilagyi PG, Shone LP, Barth R, Kouides RW, Long C, Humiston SG, Jennings J, Bennett NM: Physician practices and attitudes regarding adult immunizations. Prev Med (Baltim) 2005, 40:152-61.
• [23]Mui LWH, Chan AYS, Lee A, Lee J: Cross-sectional study on attitudes among general practitioners towards pneumococcal vaccination for middle-aged and elderly population in Hong Kong. PLoS One 2013, 8:e78210.
• [24]Sintes X, Nebot M, Izquierdo C, Ruiz L, Dominguez A, Bayas JM, Vera I, Carratala J, Sousa D: Factors associated with pneumococcal and influenza vaccination in hospitalized people aged 65 years. Epidemiol Infect 2011, 139:666-673.
• [25]Christenson B, Lundbergh P: Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection. Epidemiol Infect 2002, 129:515-24.
• [26]Lu P, Nuorti JP: Pneumococcal polysaccharide vaccination among adults aged 65 years and older, U.S., 1989–2008. Am J Prev Med 2010, 39:287-95.
• [27]Brewer NT, Chapman GB, Gibbons FX, Gerrard M, McCaul KD, Weinstein ND: Meta-analysis of the relationship between risk perception and health behavior: The example of vaccination. Heal Psychol 2007, 26:136-45.
• [28]Wong-Beringer A, Brodetsky E, Quist R: Pneumococcal vaccination in hospitalized elderly patients: role of the pharmacist. Pharmacotherapy 2003, 23:199-208.